Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage

Maxime Bertoux, Kamalini G. Ranasinghe, Marie Sarazin, Florence Pasquier, Michel Bottlaender, Leonardo Cruz De Souza, Eneida Mioshi, Michael Hornberger, Katherine Rankin, Iryna Lobach, Joel Kramer, Virginia Sturm, Brianne Bettcher, Katherine Possin, S Christine You, Amanda Lamarre, Tal Shany-Ur, Melanie Stephens, David Perry, Suzee LeeZachary Miller, Maria Gorno-Tempini, Howard Rosen, Adam Boxer, William Seeley, Gil Rabinovici, Keith Vossel, Bruce Miller

Research output: Contribution to journalComment/debatepeer-review

1 Citation (Scopus)


Based on his experience, Dr. Verslegers disagrees with “Long-term use of daily sumatriptan injections in severe drug-resistant chronic cluster headache,” which presented arguments to use sumatriptan injections on a daily basis in refractory patients with cluster headache. Instead, he suggests that ergotamine should be employed when classical treatments fail. Drs. Leone and Proietti Cecchini, authors of the study, argue that ergots are less specific than triptans, have more side effects such as nausea and vomiting, increase the risk of cardiovascular events, and can lead to ergotism when taken frequently. The authors also suggest that neurostimulation procedures can be beneficial in treating intractable chronic cluster headache. Commenting on “Cognition and neuropsychiatry in behavioral variant frontotemporal dementia by disease stage,” Bertoux et al. point to the issue …
Original languageEnglish
Pages (from-to)1523
Number of pages1
Issue number14
Publication statusPublished - 4 Oct 2016

Cite this